Articles

P2.17 The respective value of the G8 screening and the Comprehensive Geriatric Assessment (CGA) for the identification of vulnerable older patients with hematological malignancies susceptible to benefit from chemotherapy

BJH - volume 5, issue Abstract Book BHS, january 2014

S. Dubruille PhD, Y. Libert PhD, M. Roos , S. Vandenbossche , N. Meuleman MD, PhD, M. Maerevoet MD, D. Razavi MD, PhD, D. Bron MD, PhD

Read more

P2.21 Post-Transplant Lymphoproliferative Disorder following solid organ transplantation

BJH - volume 5, issue Abstract Book BHS, january 2014

J. Dallemagne , M-C. Ngirabacu MD, PhD, V. De Wilde MD, PhD, B. Bailly MD, F. Benghiat , M. Maerevoet MD, M.F. Dehou MD, N. Meuleman MD, PhD, D. Bron MD, PhD

Read more

P.07 Interim analysis of the randomized EORTC/ LYSA/FIL Intergroup H10 trial on early PET-scan driven treatment adaptation in stage I/II Hodgkin lymphoma

BJH - 2013, issue BHS Abstractbook, january 2013

P. André , E. Van den Neste MD, PhD, G. Verhoef MD, PhD, D. Bron MD, PhD, A. Van Hoof MD, PhD, P. Zachée MD, PhD, S. van Steenwegen , B. De Prijck MD, N. Straetmans MD, PhD, M. Maerevoet MD, D. Boulet , F. Offner MD, PhD, P. Pierre , V. Mathieux MD, PhD, P. Mineur MD, T. Connerotte MD, M. Federico , J. Raemaekers

Read more

P.13 G8 as a screening tool for older patients with malignant haemopathies: A surrogate for CGA?

BJH - 2013, issue BHS Abstractbook, january 2013

S. Dubruille PhD, M. Maerevoet MD, R. Roos , V. Vandenbossche , N. Meuleman MD, PhD, Y. Libert PhD, D. Bron MD, PhD

Read more

P.36 Management of fit older AML: major prognostic value of cytogenetic markers is confirmed whatever the age

BJH - 2013, issue BHS Abstractbook, january 2013

J. Nguyen , B. Bailly MD, P. Sidon , J. Hotton , M. Roos , M. Maerevoet MD, P. Lewalle MD, PhD, N. Meuleman MD, PhD, M. Paesmans , D. Bron MD, PhD

Read more
X